Today, the high prices and periodic shortages often observed with GLP-1R agonists limit equitable access, underscoring the importance of policy action, stable manufacturing, and fair distribution
There seem to be so many GLP-1 options on the market
The most common side effects include: Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are common, especially when starting the medication
The company announced last week that it was cutting the price of Wegovy for U.S
Dedicated histological reassessment studies after GLP-1 RA discontinuation in MASH patients are currently lacking, representing a major evidence gap
A researcher invests in top-tier, research-grade peptides, only to compromise the material through improper reconstitution